Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 121.22 USD -1.14% Market Closed
Market Cap: 150.4B USD

Wall Street
Price Targets

GILD Price Targets Summary
Gilead Sciences Inc

Wall Street analysts forecast GILD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GILD is 133.78 USD with a low forecast of 106.05 USD and a high forecast of 160.65 USD.

Lowest
Price Target
106.05 USD
13% Downside
Average
Price Target
133.78 USD
10% Upside
Highest
Price Target
160.65 USD
33% Upside
Gilead Sciences Inc Competitors:
Price Targets
4974
Takara Bio Inc
42% Upside
CSL
CSL Ltd
36% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
38% Upside
BMRN
Biomarin Pharmaceutical Inc
75% Upside
ARGX
argenx SE
8% Upside
ABOS
Acumen Pharmaceuticals Inc
248% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
19% Upside
ALXO
ALX Oncology Holdings Inc
123% Upside

Revenue
Forecast

Revenue Estimate
Gilead Sciences Inc

For the last 13 years the compound annual growth rate for Gilead Sciences Inc's revenue is 10%. The projected CAGR for the next 3 years is 4%.

10%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Gilead Sciences Inc

For the last 13 years the compound annual growth rate for Gilead Sciences Inc's operating income is 8%. The projected CAGR for the next 3 years is 13%.

8%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Gilead Sciences Inc

For the last 13 years the compound annual growth rate for Gilead Sciences Inc's net income is -13%. The projected CAGR for the next 3 years is 191%.

-13%
Past Growth
191%
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GILD's stock price target?
Price Target
133.78 USD

According to Wall Street analysts, the average 1-year price target for GILD is 133.78 USD with a low forecast of 106.05 USD and a high forecast of 160.65 USD.

What is Gilead Sciences Inc's Revenue forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for Gilead Sciences Inc's revenue is 10%. The projected CAGR for the next 3 years is 4%.

What is Gilead Sciences Inc's Operating Income forecast?
Projected CAGR
13%

For the last 13 years the compound annual growth rate for Gilead Sciences Inc's operating income is 8%. The projected CAGR for the next 3 years is 13%.

What is Gilead Sciences Inc's Net Income forecast?
Projected CAGR
191%

For the last 13 years the compound annual growth rate for Gilead Sciences Inc's net income is -13%. The projected CAGR for the next 3 years is 191%.

Back to Top